Challenges in conducting implantable device trials left ventricular assist devices in destination therapy

Ursula Maria Schmidt-Ott; Alan J. Moskowitz; Annetine C. Gelijns; Julie C. Choe; Michael Parides; Deborah V. Davis Ascheim

doi:10.1007/978-1-59745-004-1_11

Challenges in conducting implantable device trials left ventricular assist devices in destination therapy

Ursula Maria Schmidt-Ott, Alan J. Moskowitz, Annetine C. Gelijns, Julie C. Choe, Michael Parides, Deborah V. Davis Ascheim

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The medical device industry is characterized by a high level of innovation and the development of a continuous stream of devices that promise to enhance the life expectancy and quality of life of patients. With changes in US Food and Drug Administration (FDA) regulatory policies and increased demand for more rigorous clinical evidence by payors, physicians, and patients alike, there has been more emphasis on randomized trials to evaluate new devices as they move from bench to bedside.

Original language	English (US)
Title of host publication	Clinical Evaluation of Medical Devices
Subtitle of host publication	Principles and Case Studies: Second Edition
Publisher	Humana Press
Pages	199-215
Number of pages	17
ISBN (Print)	1588294226, 9781588294227
DOIs	https://doi.org/10.1007/978-1-59745-004-1_11
State	Published - 2006
Externally published	Yes

ASJC Scopus subject areas

Materials Science(all)
Chemistry(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-59745-004-1_11

Cite this

Schmidt-Ott, U. M., Moskowitz, A. J., Gelijns, A. C., Choe, J. C., Parides, M., & Davis Ascheim, D. V. (2006). Challenges in conducting implantable device trials left ventricular assist devices in destination therapy. In Clinical Evaluation of Medical Devices: Principles and Case Studies: Second Edition (pp. 199-215). Humana Press. https://doi.org/10.1007/978-1-59745-004-1_11

Challenges in conducting implantable device trials left ventricular assist devices in destination therapy. / Schmidt-Ott, Ursula Maria; Moskowitz, Alan J.; Gelijns, Annetine C. et al.
Clinical Evaluation of Medical Devices: Principles and Case Studies: Second Edition. Humana Press, 2006. p. 199-215.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

@inbook{79b88fb1eff742a08dfe750f675dc742,

title = "Challenges in conducting implantable device trials left ventricular assist devices in destination therapy",

abstract = "The medical device industry is characterized by a high level of innovation and the development of a continuous stream of devices that promise to enhance the life expectancy and quality of life of patients. With changes in US Food and Drug Administration (FDA) regulatory policies and increased demand for more rigorous clinical evidence by payors, physicians, and patients alike, there has been more emphasis on randomized trials to evaluate new devices as they move from bench to bedside.",

author = "Schmidt-Ott, {Ursula Maria} and Moskowitz, {Alan J.} and Gelijns, {Annetine C.} and Choe, {Julie C.} and Michael Parides and {Davis Ascheim}, {Deborah V.}",

year = "2006",

doi = "10.1007/978-1-59745-004-1_11",

language = "English (US)",

isbn = "1588294226",

pages = "199--215",

booktitle = "Clinical Evaluation of Medical Devices",

publisher = "Humana Press",

}

TY - CHAP

T1 - Challenges in conducting implantable device trials left ventricular assist devices in destination therapy

AU - Schmidt-Ott, Ursula Maria

AU - Moskowitz, Alan J.

AU - Gelijns, Annetine C.

AU - Choe, Julie C.

AU - Parides, Michael

AU - Davis Ascheim, Deborah V.

PY - 2006

Y1 - 2006

N2 - The medical device industry is characterized by a high level of innovation and the development of a continuous stream of devices that promise to enhance the life expectancy and quality of life of patients. With changes in US Food and Drug Administration (FDA) regulatory policies and increased demand for more rigorous clinical evidence by payors, physicians, and patients alike, there has been more emphasis on randomized trials to evaluate new devices as they move from bench to bedside.

AB - The medical device industry is characterized by a high level of innovation and the development of a continuous stream of devices that promise to enhance the life expectancy and quality of life of patients. With changes in US Food and Drug Administration (FDA) regulatory policies and increased demand for more rigorous clinical evidence by payors, physicians, and patients alike, there has been more emphasis on randomized trials to evaluate new devices as they move from bench to bedside.

UR - http://www.scopus.com/inward/record.url?scp=84892010311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892010311&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-004-1_11

DO - 10.1007/978-1-59745-004-1_11

M3 - Chapter

AN - SCOPUS:84892010311

SN - 1588294226

SN - 9781588294227

SP - 199

EP - 215

BT - Clinical Evaluation of Medical Devices

PB - Humana Press

ER -

Challenges in conducting implantable device trials left ventricular assist devices in destination therapy

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this